Sources of Information on Lymphoma Associated with Anti-Tumour Necrosis Factor Agents: Comparison of Published Case Reports and Cases Reported to the French Pharmacovigilance System

Author： Théophile Hélène   Schaeverbeke Thierry   Miremont-Salamé Ghada   Abouelfath Abdelilah  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.7, 2011-07, pp. : 577-585

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumour necrosis factor antagonists: Hodgkin's lymphoma: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1215, 2008-01 ,pp. : 39-39

Adis International

Access to resources Recommend Favorite

Anti-tumour necrosis factor therapy in seronegative spondyloarthritis

By Swales Catherine   Bowness Paul  

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 219-222

Royal College Of Physicians

Access to resources Recommend Favorite

Structure-Modifying Capacity of Anti-Tumour Necrosis Factor- Therapy in Ankylosing Spondylitis

By Filip De Keyser   Baeten Dominique   Filip Van den Bosch   Kruithof Elli   Verbruggen Gust   Mielants Herman   Veys Eric  

Drugs, Vol. 64, Iss. 24, 2004-01 ,pp. : 2793-2811

Adis International

Access to resources Recommend Favorite

The Future Role of Anti-Tumour Necrosis Factor- Products in the Treatment of Crohn's Disease

By van Hogezand R.A.   Verspaget H.W.  

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 299-305

Adis International

Access to resources Recommend Favorite

Anti-Tumour Necrosis Factor Therapy for Ulcerative Colitis: Evidence to Date

By Thukral Chandrashekhar   Cheifetz Adam   Peppercorn Mark A.  

Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. : 2059-2065

Adis International

Access to resources Recommend Favorite